Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax®)

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2569-2575

  Cho, Hae Wol ^a   Howard, Colin R ^b  

^a Korea National Institute of Health   (South Korea)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Hantavax vaccine; Hantavirus; Neutralising antibody

Indexed keywords

HANTAVAX; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HANTAVIRUS; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION RISK; MALE; MYALGIA; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; VERTIGO; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNIZATION; MALE; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0033522957     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00057-2     Document Type: Article

References (23)

1. Lee H.W., Groen G. Haemorrhagic fever with renal syndrome. Progress in Medical Virology. 36:1989;62-102.
2. Smadel J.E. Epidemic haemorrhagic fever. American Journal of Public Health. 43:1953;1327-1330.
3. Lee H.W., Lee P.W. Korean haemorrhagic fever. 1. Demonstration of causative antigen and antibodies. Korean Journal of Internal Medicine. 19:1976;371-383.
4. Lee H.W., Lee P.W., Johnson K.M. Isolation of the etiologic agent of Korean haemorrhagic fever. Journal of Infectious Diseases. 137:1978;298-308.
5. Elliot L.H., Ksiaxek T.G., Rollin T.G., et al. Isolation of the causative agent of hantavirus pulmonary syndrome. American Journal of Tropical Medicine and Hygiene. 51:1994;102-108.
6. Peters CJ, CDC Hantavirus Task Force. Hantavirus pulmonary syndrome 11. Epidemiology abstract from twenty-eight joint working conferences on viral diseases, 1994.
7. Lee H.W., An C.N. Development of vaccine against haemorrhagic fever with renal syndrome. Journal of Korean Society of Virology. 18:1988;143-148.
8. World Health Organisation. Working group on viral haemorrhagic fever and viral neurological diseases. World Health Organisation, 1987.
9. World Health Organisation. Working group on the development of a rapid diagnostic method and vaccine for haemorrhagic fever with renal syndrome, 1992.
10. French G.R., Foulke R.S., Brand O.A., et al. Korean haemorrhagic fever: propagation of the etiologic agent in a cell line of human origin. Science. 211:1981;1046-1048.
11. Lee H.W. Haemorrhagic fever with renal syndrome. Progress in Medical Virology. 36:1989;62-102.
12. Oya A. Japanese encephalitis vaccine: the vaccination. International Medical Foundation of Japan 1976; 69-72.
13. Yoo D.W., Kang C.Y. Genomic comparisons among members of hantavirus group. Mahy B.W.J., Kolakofsky D., The Biology of Negative Stranded Viruses. 1987;424-431 Elsevier, New York.
14. Duermeyer W. An outbreak of hepatitis A investigated by immune electron microscopy and enzyme-linked immunosorbent assay. Scandanavian Journal of Infectious Diseases. 11:1979;97-98.
15. Meegan J.M., LeDuc J.W. Enzyme immunoassays. Lee H.W., Dalrymple J.M., Manual of Haemorrhagic Fever with Renal Syndrome. 1998;83-87 Korea University, Seoul.
16. Schmaljohn CS, Arikawa J, Dalrymple JM, et al. Expression of the envelope glycoprotein of hantaan virus with vaccinia and baculovirus recombinants. Genetic and Pathogenicity of Negative Strand Viruses. Elsevier, 1989. p. 58-66.
17. Schmaljohn C.S. Nucleotide sequence of the L genome segment of Hantaan virus. Nucleic Acids Research. 18:1990;6728.
18. Schmaljohn C.S., Hasy S.E., Dalrymple J.M. Preparation of candidate vaccinia vectored vaccine for haemorrhagic fever with renal syndrome. Vaccine. 10:1992;10-13.
19. Nakamura J. Studies on purified Japanese encephalitis vaccine. NIBS Bulletin of Biological Research. 8:1969;78-99.
20. Yamanishi K., Tanishita O., Tamura M., et al. Development of an inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. Vaccine. 6:1988;278-282.
21. Song G., Huang Y.C., Hang C.S., et al. Preliminary trial of an inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine. 10:1992;214-216.
22. Zhu Z.Y., Tang H.Y., Li Y.J., et al. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans. Chinese Medical Journal. 107:1994;167-170.
23. Lu Q., Zhu Z., Weng J. Immune responses to inactivated vaccine in people naturally infected with hantaviruses. Journal of Medical Virology. 49:1996;333-335.